Participants:18–64 years · 65+ years
Substances:1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One

Contact Research Centre

Arteriosclerosis

Not recruiting

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Austria

Participants:18–64 years · 65+ years

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

Registered drug

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Jnj-77242113

Contact Research Centre

Chronic kidney disease

Not recruiting

Registered drugNo placebo

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Dyslipidaemia

Not recruiting

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Evolocumab

Contact Research Centre

Ischaemic stroke+2

Not recruiting

Investigational

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Asundexian

Contact Research Centre

Acute coronary syndrome

Not recruiting

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Small cell lung cancer extensive stage

Not recruiting

Registered drugNo placebo

Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Argipressin

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Find therapies in clinical trials near you – page 3

53 trials match your criteria

Atrial fibrillation

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Arteriosclerosis

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Arteriosclerosis

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Non-small cell lung cancer

Study on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer

Arteriosclerosis

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Psoriasis

Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

Chronic kidney disease

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Dyslipidaemia

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Ischaemic stroke+2

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Acute coronary syndrome

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Small cell lung cancer extensive stage

Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

Non-small cell lung cancer metastatic

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.